Seeking Alpha

Shares of Antares Pharma (ATRS -9.1%) continue their slide today after its second-quarter loss...

Shares of Antares Pharma (ATRS -9.1%) continue their slide today after its second-quarter loss widened and results missed analyst estimates on Wednesday. Net profit was hit by bottom line pressure from higher investment expenses related to the development of its Vibex MTX auto injector for the treatment of rheumatoid arthritis, along with an increase in support personnel.
Comments (9)
  • BrennanNoall
    , contributor
    Comments (60) | Send Message
     
    This is one of the best long term bios I have ever seen. I'm long with a $14.25 price target with 24 months.
    10 Aug 2012, 01:40 PM Reply Like
  • vitosoranno1
    , contributor
    Comments (1098) | Send Message
     
    I agree. Antares is a sure thing.
    10 Aug 2012, 01:46 PM Reply Like
  • horseman
    , contributor
    Comments (184) | Send Message
     
    I do hope you are right, both medically and financially. I think you are!
    10 Aug 2012, 02:09 PM Reply Like
  • mikeyWin
    , contributor
    Comments (3) | Send Message
     
    TheStreet article didnt help its gain today either. ATRS has good management and is headed in a positive direction.
    10 Aug 2012, 02:42 PM Reply Like
  • dhdhoora
    , contributor
    Comments (379) | Send Message
     
    Agree with comments. TheStreet note and downgrade must have been computer generated. (And they have to stand by Jimmy Cramer). Nobody really looking at the company would give any pause to the short-term revenue and EPS number. ATRS is still primarily a development stage company -- the fact that it has some income is a plus. The fact that it has zero debt and about 15 quarters of cash burn available is unheard of in the pharma and pharma device sectors.

     

    The real action starts as Vibex MTX moves along the approval pipeline and the company makes its decision on whether to internally sell or externally distribute the product. (My guess is that they are going to do this in-house.) In any case, the hysteria stirred by this "miss" has created quite a buying opportunity...

     

    All the very best,
    Don
    10 Aug 2012, 03:11 PM Reply Like
  • snyderjam1
    , contributor
    Comment (1) | Send Message
     
    I agree, going long on atrs is a very smart move. You will be rewarded for sticking with this!! I feel this is one of those opportunities that people will look back at and say "I should have"
    11 Aug 2012, 08:52 AM Reply Like
  • renella88
    , contributor
    Comment (1) | Send Message
     
    I live in Europe and I am always surprised to see the reactions to short term results and performances. The present stock value is related to future potentialities which do not changes from one day to another. For istance, the probability for Antares of being bought by a larger company is still there; the large investment done is in part a guarantee for the future. The pressure of the stock market on company management is negative; instead of prosecuting long term objectives and creating value, the management is pressed by short term results. That often are in contrast with long term growth. performances
    11 Aug 2012, 10:37 AM Reply Like
  • duvas1952
    , contributor
    Comments (14) | Send Message
     
    Any investor who believes that a earnings report, at this stage of Antares long term (and might be fairly short term soon), is not a true investor but is one of those investors who are in the stock market to truly specualate on day to day price movements.

     

    A Pharma company with direct ties to companies like Teva Pharmaceutical Industries, Watson Pharmaceuticals, Eli Lilly plus other agreements with many other pharma companies has their head stuck in the sand.

     

    Did I mention that two top executives from Eli have been hired by Antares (do I smell takeover in the not to distant future)?

     

    Shortly the VIBEX MTX development program will be finished and approved and the outlook for price appreciation is tremendous. On top of all this they HAVE A SIZABLE CASH RESERVE, unheard of from a small pharma company which usually burns through cash in developing their new products.

     

    All I can say is if you are not a day trader and want to post HUGE gains in the next six months, Antares is THE company that comes along once in a lifetime!!!
    12 Aug 2012, 10:06 PM Reply Like
  • spybreaker
    , contributor
    Comments (235) | Send Message
     
    why was there a ~6% pop today? can't find any news on this.
    18 Sep 2012, 05:37 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|